Literature DB >> 848352

An eleven-year follow-up on 64 subjects with M-components.

U Axelsson.   

Abstract

In a medical health survey in 1964 of 6995 subjects, 64 persons with M-components were detected by serum electrophoresis. One had clearcut signs of myelomatosis and one had lymphatic leukemia. Eleven years later 27 persons had died. In the case with lymphatic leukemia the disease had changed after 6 years into a myelomatosis. One person died after 9 years from a malignant lymphoma. Among the 37 persons still alive there seemed to be no clustering of diseases. The whole series represents an observation time of 487 years. No more myelomas or lymphomas were detected. One M-component had disappeared.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 848352     DOI: 10.1111/j.0954-6820.1977.tb15676.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital.

Authors:  V Malacrida; D De Francesco; G Banfi; F A Porta; P G Riches
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

2.  Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins.

Authors:  S N Kahn; P G Riches; J Kohn
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

3.  Acquired inhibitor to human factor VIII associated with paraproteinaemia and subsequent development of chronic lymphatic leukaemia.

Authors:  P R Kelsey; M J Leyland
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-17

4.  Significance of 801 monoclonal proteins detected during 7 years of screening in a district general hospital.

Authors:  L Smith; R A Adams; C Burston
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

5.  ["Benign" monoclonal gammopathy and chronic lymphatic leukemia in a patient with Noonan syndrome].

Authors:  J Riederer
Journal:  Med Klin (Munich)       Date:  1998-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.